FinTrust Capital Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,235
| Closed | -$40.5K | – | 1249 |
|
|
2023
Q4 | $40.5K | Hold |
1,235
| – | – | 0.01% | 532 |
|
|
2023
Q3 | $34.4K | Hold |
1,235
| – | – | 0.01% | 535 |
|
|
2023
Q2 | $34.9K | Hold |
1,235
| – | – | 0.01% | 509 |
|
|
2023
Q1 | $34.9K | Hold |
1,235
| – | – | 0.01% | 508 |
|
|
2022
Q4 | $34.9K | Hold |
1,235
| – | – | 0.01% | 508 |
|
|
2022
Q3 | $40K | Hold |
1,235
| – | – | 0.01% | 549 |
|
|
2022
Q2 | $45K | Hold |
1,235
| – | – | 0.01% | 545 |
|
|
2022
Q1 | $57K | Hold |
1,235
| – | – | 0.01% | 531 |
|
|
2021
Q4 | $76K | Sell |
1,235
-93
| -7% | -$5.72K | 0.02% | 476 |
|
|
2021
Q3 | $99K | Hold |
1,328
| – | – | 0.03% | 413 |
|
|
2021
Q2 | $123K | Buy |
1,328
+1,235
| +1,328% | +$114K | 0.03% | 367 |
|
|
2021
Q1 | $8K | Hold |
93
| – | – | ﹤0.01% | 929 |
|
|
2020
Q4 | $9K | Hold |
93
| – | – | ﹤0.01% | 846 |
|
|
2020
Q3 | $6 | Buy |
+93
| New | +$6 | ﹤0.01% | 911 |
|
|
2019
Q1 | – | Sell |
-2,390
| Closed | -$57K | – | 1242 |
|
|
2018
Q4 | $57K | Buy |
+2,390
| New | +$57K | 0.03% | 348 |
|